Journal of Psychoactive Drugs
译名:精神活性药物杂志
JOURNAL OF PSYCHOACTIVE DRUGS
1-3
2026
影响因子区间
—
平台估算
5%
2025
中国作者发文占比
—
收费
期刊简介:An authoritative peer-reviewed periodical containing timely information of a multidisciplinary nature for clinicians and other professionals in the drug abuse field; Journal of Psychoactive Drugs consistently addresses complex issues such as the disease concept of addiction, drugs and mental health, use and abuse of hallucinogens, ethnographic drug research, drug dependence and the family and more! For over fifty years, the Journal of Psychoactive Drugs has been on the leading edge of developments in the study of substance use and abuse from a multidisciplinary perspective. It was the first journal established in the United States to focus on psychoactive drug abuse, and continues to introduce groundbreaking work in topics such as drug use and criminality, therapeutic communities, dual diagnosis, psychotherapy/counseling, medication-assisted treatment, and culturally relevant substance abuse treatment. The Journal of Psychoactive Drugs publishes research, case reports and other studies dealing with the experimental and policy issues of drug use as well as the treatment of drug abuse. Publication office: Taylor & Francis, Inc., 530 Walnut Street, Suite 850, Philadelphia, PA 19106
【译文】权威的同行评审期刊,为药物滥用领域的临床医生和其他专业人员提供及时的多学科信息; 《精神活性药物杂志》始终致力于解决复杂的问题,例如成瘾的疾病概念、药物和心理健康、致幻剂的使用和滥用、民族志药物研究、药物依赖和家庭等等!五十多年来,《精神活性药物杂志》一直处于从多学科角度研究药物使用和滥用的前沿。它是美国第一本专注于精神药物滥用的期刊,并继续介绍药物使用和犯罪、治疗社区、双重诊断、心理治疗/咨询、药物辅助治疗和文化相关的药物滥用治疗等主题的开创性工作。 《精神活性药物杂志》发表有关药物使用的实验和政策问题以及药物滥用治疗的研究、病例报告和其他研究。出版办公室:Taylor & Francis, Inc., 530 Walnut Street, Suite 850, Philadelphia, PA 19106

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q2 | 暂无 |
| 中科院分区 | 4区 | 暂无 |
| 影响因子区间 | 1-3 | 暂无 |